ELRIZ XL SYRUP is a combination of Ambroxol and Levocetirizine which belongs to the group of medicines called Mucolytics and Antihistamines respectively. It is used to provide symptomatic relief in allergic bronchitis and asthma associated allergic rhinitis in adults and children (aged 6 years and above).
Allergic bronchitis is a condition that occurs due to inflammation of the bronchial tubes by an allergic reaction which is generally characterized by symptoms such as cough, wheezing, chest tightness and weakness. Allergic asthma is a breathing condition where the airways tighten when an allergen is inhaled such as pollen and mold spores which is generally characterized by symptoms such as shortness of breath, coughing, wheezing and stuffy nose.
Avoid taking ELRIZ XL SYRUP, if you are allergic to Ambroxol, Levocetirizine or cetrizine or have end stage renal disease (kidney failure). Before taking ELRIZ XL SYRUP, inform your doctor if you have liver problems such as hepatic impairment.
ELRIZ XL SYRUP is not recommended for use during pregnancy and in breastfeeding women as it can pass through breastmilk. ELRIZ XL SYRUP is not recommended for use in children (aged 6 to 11 years) with impaired renal function and it is used with caution in children and adolescents (aged below 18 years) after consulting the doctor.
The most common side effects of taking ELRIZ XL SYRUP are headache, excessive sleepiness, dry mouth, weakness and decreased muscle strength. Consult your doctor if any of the side effects worsen.
ELRIZ XL SYRUP provides symptomatic relief from allergic bronchitis and asthma associated allergic rhinitis, where Ambroxol provides relief from symptoms of allergic bronchitis and rhinitis by thinning and loosening the mucus in the nose, windpipe and lungs. Levocetirizine provides relief from itching, swelling and rashes by blocking the effects of a chemical messenger called histamine in the body which is responsible for producing allergic reactions in the body.
Take ELRIZ XL SYRUP as advised by your physician. Use a measuring or spoon to properly measure the dose. Shake well before use. Your doctor will decide the correct dose and duration for you depending upon your age, body weight and disease condition.
Stop taking ELRIZ XL SYRUP and contact your doctor if you experience any of the following side effects:
Headache:
If ELRIZ XL SYRUP causes headache, then take rest and drink plenty of fluids. Try to avoid drinking alcohol. Ask your doctor to recommend a painkiller. Headaches should usually go away after the first week of taking ELRIZ XL SYRUP. If headaches last more than a week or severe, inform your doctor.
Dry mouth :
Sip water regularly and other sugar free liquids. Do not use mouthwashes that contain alcohol because they can make your mouth dry, use mouthwash that is used only for dry mouth. Limit your caffeine intake. Avoid smoking or using tobacco products. Consult your doctor if the symptom does not improve.
Nausea:
Try to take ELRIZ XL SYRUP with or just after a meal or a snack. Stick to simple meals. Avoid eating oil rich or spicy food. Consult and inform your doctor if the symptom gets worse.
Constipation:
Try to eat high-fiber foods such as vegetables, cereals, fresh fruit and drink plenty of water. Involve in regular exercise (such as going for a daily walk or run) and if this does not help, consult and inform your doctor for receiving alternate treatments for constipation.
ELRIZ XL SYRUP is not recommended to be used by pregnant women. Consult your doctor before taking the medicine.
ELRIZ XL SYRUP is not recommended for use in breast-feeding women as it may pass through the breast milk. Consult your doctor before taking this medicine.
ELRIZ XL SYRUP should be used with caution while driving and using machines since it needs complete mental alertness and motor coordination. Consult your doctor for advice.
Avoid consumption of alcohol while taking ELRIZ XL SYRUP because it may reduce alertness and might cause impairment of the central nervous system.
ELRIZ XL SYRUP is not recommended for use in patients with end stage renal disease (kidney failure) and in patients who undergo hemodialysis (process of cleaning blood through a machine where the kidney fails to function). It should be taken with caution in patients with mild, moderate and severe renal impairment. Consult your doctor before taking it.
ELRIZ XL SYRUP should be used with caution in patients with hepatic impairment. Consult your doctor before taking ELRIZ XL SYRUP.
Do not take ELRIZ XL SYRUP if you are allergic to Ambroxol or Levocetirizine or any of its ingredients or to cetirizine.
Use in Pediatrics:
ELRIZ XL SYRUP is generally not recommended for use in children (aged 6 to 11 years) with impaired renal function. It is used with caution in children and adolescents (aged below 18 years). Consult your child’s doctor for advice.
Use in Geriatrics:
ELRIZ XL SYRUP should be used with caution in elderly patients (aged 65 years and above). Consult your doctor before taking ELRIZ XL SYRUP.
A. Drug-Drug Interactions:
Before taking ELRIZ XL SYRUP, inform your doctor, if you are taking any of the following medicines:
Overdosage:
If you or anyone else accidentally takes too much of ELRIZ XL SYRUP, consult your doctor immediately or visit the nearby hospital. Symptoms of overdose are drowsiness in adults and initially agitation and restlessness, followed by drowsiness in children.
Drug | : | Ambroxol, Levocetirizine (XL) |
Pharmacological Category | : | Mucolytics, Antihistamines |
Therapeutic Indication | : | Symptomatic relief in allergic bronchitis and asthma associated allergic rhinitis |
Dosage Forms | : | Syrup |
What is ELRIZ XL SYRUP used for?
ELRIZ XL SYRUP is used in the treatment of allergic bronchitis and asthma associated allergic rhinitis in adults and children (aged 6 years and above) which are generally characterized symptoms such as cough, wheezing, chest tightness, weakness, shortness of breath and stuffy nose.
Who should avoid taking ELRIZ XL SYRUP?
ELRIZ XL SYRUP is not recommended for use in pregnant and breastfeeding women and in children below 6 years of age especially with renal impairment. It is not recommended to be used by patients who are allergic to Ambroxol, Levocetirizine or cetirizine and in patients who have end stage renal disease (kidney failure).
What are the side effects of ELRIZ XL SYRUP?
The most common side effects of taking ELRIZ XL SYRUP are headache, excessive sleepiness, dry mouth, weakness and decreased muscle strength. Consult your doctor if any of the side effect worsens.
What happens if you take more ELRIZ XL SYRUP than your required dose?
If you or anyone else accidentally takes too much of ELRIZ XL SYRUP, consult your doctor immediately or visit the nearby hospital. Symptoms of overdose are drowsiness in adults and initially agitation and restlessness, followed by drowsiness in children.
Can ELRIZ XL SYRUP be taken by pregnant or breastfeeding women?
ELRIZ XL SYRUP is not recommended for use in pregnant women. It is also not recommended to be used in breastfeeding women since it may pass through mother’s milk. Consult your doctor before taking this medicine.
1. KD. Tripathi. Drugs for Cough and Bronchial Asthma and Histamine and Antihistaminics. Seventh edition. 2013. Page – 167 & 219
2. Boehringer Ingelheim. Relative Bioavailability of Ambroxol Hydrochloride Lozenge in Comparison to Ambroxol Hydrochloride Syrup (Mucosolvan) in Healthy Female and Male Volunteers. NIH U.S. National Library of Medicine ClinicalTrials.gov. [Revised in July 2014] [Accessed on 17th June 2022] https://clinicaltrials.gov/ct2/show/NCT02194296
3. UCB Pharma. Efficacy and Safety of Levocetirizine for Treatment of Recurrent Cough Associated With Other Allergic Symptoms in Children. NIH U.S. National Library of Medicine ClinicalTrials.gov. [Revised in December 2013] [Accessed on 17th June 2022] https://www.clinicaltrials.gov/ct2/show/NCT00520754
4. Zuventus HealthCare Ltd. Elriz Xl Syrup. [Revised in 2013] [Accessed on 17th June 2022] http://www.zuventus.co.in/doctor_wise_products_selected.aspx?Medi_Id=143
5. Delpharma Reims. Mucosolvan forte. [Revised in March 2013] [Accessed on 17th June 2022] https://pharmacia1.com/wp-content/uploads/2015/08/mucosolvan-patient-info.-leaflet.pdf
6. UCB, Inc. U.S. Food & Drug Administration. [Revised in January 2008] [Accessed on 17th June 2022] https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/022064s009lbl.pdf
The contents of this website are for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Do not disregard professional medical advice or delay in seeking it because of something you have read on this website.